JENNIFER STEVICK: Open Payments
NPI 1265700595 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,333 in 53 payments from 22 companies in 2025. Trend: 2023 $942 · 2024 $1,228 · 2025 $1,333
Food & beverage: $1,054Education: $279
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $192 |
| AstraZeneca Pharmaceuticals LP | 7 | $130 |
| Merck Sharp & Dohme LLC | 5 | $111 |
| Lilly USA, LLC | 2 | $109 |
| Novartis Pharmaceuticals Corporation | 6 | $108 |
| SEAGEN INC. | 1 | $93 |
| Daiichi Sankyo Inc. | 3 | $72 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| SOBI, INC | 3 | $64 |
| Janssen Biotech, Inc. | 3 | $59 |
Products named: Trodelvy, KEYTRUDA, OPDIVO, Enhertu, Vonjo, KISQALI, Lenvima, DARZALEX.
Industry payments across GA — which companies pay providers there.
